
Sign up to save your podcasts
Or


The editors also review the management of scarlet fever (http://dtb.bmj.com/content/55/9/102.2) and consider two drugs (baricitinib and tofacitinib) recently licensed for the management of rheumatoid arthritis (http://dtb.bmj.com/content/55/9/102.1).
By BMJ Group4.8
44 ratings
The editors also review the management of scarlet fever (http://dtb.bmj.com/content/55/9/102.2) and consider two drugs (baricitinib and tofacitinib) recently licensed for the management of rheumatoid arthritis (http://dtb.bmj.com/content/55/9/102.1).

1,085 Listeners

852 Listeners

164 Listeners

2,099 Listeners

2,000 Listeners

38 Listeners

48 Listeners

93 Listeners

10 Listeners

6 Listeners

3 Listeners

2 Listeners

3 Listeners

11 Listeners

40 Listeners

14 Listeners

1 Listeners

52 Listeners

0 Listeners

6 Listeners

15 Listeners

19 Listeners

3 Listeners

26 Listeners

978 Listeners

23 Listeners

9 Listeners

24 Listeners

168 Listeners

3,842 Listeners

2,139 Listeners

922 Listeners

7 Listeners

0 Listeners